Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Disease Solution Services generated ¥93,227 thousand, up 80.5% year on year, due to the recognition of revenue from a new PHR service ordered by a pharmaceutical company. Welby Myカルテ services generated ¥40,201 thousand, down 41.7% year on year, due to timing differences in the recognition of certain projects and other factors.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥133 million (YoY +10.7%) |
| Operating profit | ¥-157 million |
| Ordinary income | ¥-157 million |
| Profit attributable to owners of the parent | ¥-153 million |
| Net income per share | -¥18.41 |
| Equity ratio | End of the current fiscal period 15 / End of previous period 20.9 |
| Total assets | ¥847 million |
| Net assets | ¥210 million |
| Full-year earnings forecast | Net Sales ¥1,466 million (YoY +130.5%) / Operating profit ¥-30 million / Ordinary income Not disclosed / Net income Not disclosed |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Depreciation and amortization | ¥344 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Newly consolidated: 0 companies; excluded: 0 companies (company names: —) |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 8,435,582 |
| Treasury Shares at Period-End | 30 |
| Factors Behind Changes in Business Performance | Disease Solution Services generated ¥93,227 thousand, up 80.5% year on year, due to the recognition of revenue from a new PHR service ordered by a pharmaceutical company. Welby Myカルテ services generated ¥40,201 thousand, down 41.7% year on year, due to timing differences in the recognition of certain projects and other factors. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue from Disease Solution Services increased due to the recognition of revenue from a new PHR service ordered by a pharmaceutical company, while revenue from the Welby Myカルテ service declined due to timing differences in the recognition of certain projects and other factors.